HealthStream Announces Second Quarter 2013 Results
Highlights:
-
Revenues of
$31.9 million in the second quarter of 2013, up 24% from revenues of$25.8 million in the second quarter of 2012 -
Operating income of
$4.1 million in the second quarter of 2013, up 2% from operating income of$4.0 million in the second quarter of 2012 -
Net income of
$2.4 million in both the second quarter of 2013 and the second quarter of 2012, and earnings per share (EPS) of$0.09 per share (diluted) for both the second quarter of 2013 and the second quarter of 2012 -
Adjusted EBITDA1 of
$6.4 million in the second quarter of 2013, up 8% from$5.9 million in the second quarter of 2012
Financial Results:
Second Quarter 2013 Compared to Second Quarter 2012
Revenues for the second quarter of 2013 increased
Revenues from HealthStream Learning & Talent Management increased by
Revenues from
Generally accepted accounting principles (GAAP) require companies to
write down beginning balances of acquired deferred revenue balances as
part of "fair value" accounting as defined by GAAP. During the second
quarter of 2013,
Operating income for the second quarter of 2013 increased by two percent
to
Net income was
Adjusted EBITDA (which we define as net income before interest, income
taxes, share-based compensation, and depreciation and amortization)
increased by eight percent to
At
Year-to-Date 2013 Compared to Year-to-Date 2012
For the first six months of 2013, revenues were
Other Business Updates
At
"Annualized Revenue per Implemented Subscriber" is a measure of our progress in growing the value of our customer base. Annualized Revenue per Implemented Subscriber, which was introduced last quarter, represents the quarter's revenue from Internet-based subscription products annualized, then divided by the quarter's average total implemented subscribers. The following table shows the metric for the second quarter of 2013 and the preceding seven quarters.
Learning & Talent Management — Annualized Revenue per Implemented Subscriber
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
|||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||
Note: Internet-based subscription products include subscriptions to our platform, plus courseware/content subscriptions. The above metric does not include revenues from SimCenter; the Company reports those revenues separately as part of our SimVentures collaborative arrangement.
Based on the number of subscribers, our renewal rate was 102 percent in the second quarter of 2013. Our renewal rate for the number of subscribers reflects the number of subscribers that were up for renewal in the quarter that chose to renew plus the addition of new subscribers on these accounts, compared to previously contracted amounts—which means that the renewal rate can exceed 100 percent. The renewal rate based on subscribers for the second quarter of 2013 compares to a renewal rate of 108 percent during the second quarter of 2012.
Based on contract value, our renewal rate was 104 percent in the second quarter of 2013. Our renewal rate for contract value reflects any pricing adjustment that may occur at renewal along with increases in contract value due to the addition of new subscribers as compared to previously contracted amounts—which means that the renewal rate can exceed 100 percent. Our calculation of this renewal rate includes only the base subscriptions to our platform; it does not include the purchase of additional products or content purchased prior to or at the time of renewal. The renewal rate based on contract value for the second quarter of 2013 compares to a renewal rate of 102 percent during the second quarter of 2012.
For the trailing four quarters ended
With CMS' deadline of
Post-Acute Care Business Update
Following the Company's launch of its strategy last quarter to offer our
learning and talent management suite of solutions to the post-acute care
market, two industry leading customers were contracted: one in the
senior living space (contracted in
As we announced last week, Brookdale Senior Living, the nation's largest
senior living provider, chose our learning and talent management
solutions for their 50,000 associates in a five-year agreement.
Brookdale and
In the home health care space, Almost Family, a leading home healthcare
provider in the U.S., contracted with
Financial Outlook for 2013
The Company revised its previous guidance and anticipates consolidated revenues for 2013 to grow between 23 to 25 percent over full-year 2012. We anticipate revenue growth in the Learning & Talent Management segment to be in the 26 to 28 percent range and the Research segment's revenues to increase approximately eight to 10 percent.
We anticipate that 2013 full-year operating income will be approximately
six to 10 percent over full-year 2012, capital expenditures will be
between
Commenting on second quarter 2013 results,
A conference call with
Use of Non-GAAP Financial Measures
This press release contains certain non-GAAP financial measures, including non-GAAP net income, non-GAAP operating income, non-GAAP revenue, and adjusted EBITDA, which are used by management in analyzing its financial results and ongoing operational performance.
In order to better assess the Company's financial results, management believes that income before interest, income taxes, share-based compensation, depreciation and amortization ("adjusted EBITDA") is an appropriate measure for evaluating the operating performance of the Company because adjusted EBITDA reflects net income adjusted for non-cash and non-operating items. Adjusted EBITDA is also used by many investors to assess the Company's results from current operations. Adjusted EBITDA is a non-GAAP financial measure and should not be considered as a measure of financial performance under GAAP. Because adjusted EBITDA is not a measurement determined in accordance with GAAP, it is susceptible to varying calculations. Accordingly, adjusted EBITDA, as presented, may not be comparable to other similarly titled measures of other companies.
Recently the Company has acquired businesses whose net tangible assets include deferred revenue. In accordance with GAAP reporting requirements, the Company may record a write down of deferred revenue to fair value as defined in GAAP. If the Company is required to record a write-down of deferred revenue, it may result in lower recognized revenue. In order to provide more accurate trends and comparisons of the Company's revenues, operating income, and net income, management believes that adding back the deferred revenue write-down associated with fair value accounting for acquired businesses provides a better indication of the ongoing performance of the Company. Both on a quarterly and year-to-date basis, the revenue for the acquired contracts is deferred and typically recognized over a one-year period, so our GAAP revenues for the one-year period after the acquisition will not reflect the full amount of revenues that would have been reported if the acquired deferred revenue was not written down to fair value.
These non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance which are prepared in accordance with GAAP and may be different from non-GAAP financial measures used by other companies. Investors are encouraged to review the reconciliations of our GAAP to non-GAAP financial measures, which are set forth below in this release.
About
1 Adjusted EBITDA is a non-GAAP financial measure. A reconciliation of adjusted EBITDA to net income is included in this release.
|
||||||||||||||||||||
Summary Financial Data | ||||||||||||||||||||
(In thousands, except per share data) | ||||||||||||||||||||
Unaudited | ||||||||||||||||||||
Three Months Ended
|
Six Months Ended
|
|||||||||||||||||||
2013 |
2012 |
2013 |
2012 |
|||||||||||||||||
Revenues | $ | 31,919 | $ | 25,841 | $ | 61,565 | $ | 49,514 | ||||||||||||
Operating expenses: | ||||||||||||||||||||
Cost of revenues (excluding depreciation and amortization) |
12,871 |
10,167 |
25,391 |
19,742 |
||||||||||||||||
Product development | 2,778 | 2,182 | 5,384 | 4,051 | ||||||||||||||||
Sales and marketing (1) |
5,450 | 4,678 | 10,650 | 10,214 | ||||||||||||||||
Other general and administrative | 4,817 | 3,201 | 9,089 | 6,019 | ||||||||||||||||
Depreciation and amortization | 1,897 | 1,572 | 3,773 | 3,106 | ||||||||||||||||
Total operating expenses | 27,813 | 21,800 | 54,287 | 43,132 | ||||||||||||||||
Operating income | 4,106 | 4,041 | 7,278 | 6,382 | ||||||||||||||||
Other income | 28 | 26 | 75 | 45 | ||||||||||||||||
Income before income taxes | 4,134 | 4,067 | 7,353 | 6,427 | ||||||||||||||||
Income tax provision | 1,712 | 1,640 | 2,991 | 2,580 | ||||||||||||||||
Net income | $ | 2,422 | $ | 2,427 | $ | 4,362 | $ | 3,847 | ||||||||||||
Net income per share: | ||||||||||||||||||||
Net income per share, basic | $ | 0.09 | $ | 0.09 | $ | 0.16 | $ | 0.15 | ||||||||||||
Net income per share, diluted | $ | 0.09 | $ | 0.09 | $ | 0.16 | $ | 0.14 | ||||||||||||
Weighted average shares outstanding: | ||||||||||||||||||||
Basic | 26,722 | 26,127 | 26,531 | 26,063 | ||||||||||||||||
Diluted | 27,649 | 27,501 | 27,529 | 27,418 | ||||||||||||||||
(1) Includes approximately |
||||||||||||||||||||
|
|||||||||||||
Condensed Consolidated Balance Sheets | |||||||||||||
(In thousands) | |||||||||||||
Unaudited | |||||||||||||
|
|
||||||||||||
2013 |
2012(1) |
||||||||||||
ASSETS | |||||||||||||
Current assets: | |||||||||||||
Cash and cash equivalents | $ | 54,651 | $ | 41,365 | |||||||||
Marketable securities — short term | 46,777 | 51,952 | |||||||||||
Accounts and unbilled receivables, net | 22,554 | 16,511 | |||||||||||
Prepaid and other current assets | 5,244 | 6,004 | |||||||||||
Deferred tax assets, current | 549 | 2,459 | |||||||||||
Total current assets | 129,775 | 118,291 | |||||||||||
Capitalized software development, net | 10,391 | 9,732 | |||||||||||
Property and equipment, net | 7,491 | 7,820 | |||||||||||
Goodwill and intangible assets, net | 37,471 | 38,104 | |||||||||||
Other assets | 758 | 581 | |||||||||||
Total assets | $ | 185,886 | $ | 174,528 | |||||||||
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||||||
Current liabilities: | |||||||||||||
Accounts payable, accrued and other liabilities | $ | 11,457 | $ | 11,886 | |||||||||
Deferred revenue | 28,541 | 23,146 | |||||||||||
Total current liabilities | 39,998 | 35,032 | |||||||||||
Deferred tax liabilities, non-current |
6,474 |
6,474 |
|||||||||||
Other long-term liabilities | 675 | 826 | |||||||||||
Total liabilities | 47,147 | 42,332 | |||||||||||
Shareholders' equity: | |||||||||||||
Common stock | 160,254 | 158,020 | |||||||||||
Comprehensive income (loss) | (35 | ) | 18 | ||||||||||
Accumulated deficit | (21,480 | ) | (25,842 | ) | |||||||||
Total shareholders' equity | 138,739 | 132,196 | |||||||||||
Total liabilities and shareholders' equity | $ | 185,886 | $ | 174,528 | |||||||||
(1) Derived from audited financial statements contained in the
Company's filing on Form 10-K for the year ended |
|||||||||||||
|
||||||||||||
Condensed Consolidated Statement of Cash Flows | ||||||||||||
(In thousands) | ||||||||||||
Unaudited | ||||||||||||
Six Months Ended | ||||||||||||
|
|
|||||||||||
2013 |
2012 |
|||||||||||
Operating activities: | ||||||||||||
Net income | $ | 4,362 | $ | 3,847 | ||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
Depreciation and amortization | 3,773 | 3,106 | ||||||||||
Deferred income taxes | 2,991 | 2,580 | ||||||||||
Share-based compensation | 710 | 541 | ||||||||||
Bad debt expense | 95 | 50 | ||||||||||
Changes in assets and liabilities: | ||||||||||||
Accounts and unbilled receivables | (6,144 | ) | (2,319 | ) | ||||||||
Prepaid and other assets | 1,468 | 1,063 | ||||||||||
Accounts payable, accrued and other liabilities | (1,601 | ) | (2,346 | ) | ||||||||
Deferred revenue | 5,387 | 2,411 | ||||||||||
Net cash provided by operating activities | 11,041 | 8,933 | ||||||||||
Investing activities: | ||||||||||||
Business combinations, net of cash acquired | (181 | ) | (2,904 | ) | ||||||||
Changes in marketable securities and other investments | 4,158 | (52,309 | ) | |||||||||
Purchases of property and equipment | (1,243 | ) | (2,009 | ) | ||||||||
Payments associated with capitalized software development | (2,013 | ) | (1,996 | ) | ||||||||
Net cash provided by (used in) investing activities | 721 | (59,218 | ) | |||||||||
Financing activities: | ||||||||||||
Proceeds from exercise of stock options | 1,682 | 722 | ||||||||||
Taxes paid related to net settlement of equity awards | (158 | ) | -- | |||||||||
Net cash provided by financing activities | 1,524 | 722 | ||||||||||
Net increase (decrease) in cash and cash equivalents | 13,286 | (49,563 | ) | |||||||||
Cash and cash equivalents at beginning of period | 41,365 | 76,904 | ||||||||||
Cash and cash equivalents at end of period | $ | 54,651 | $ | 27,341 | ||||||||
Reconciliation of GAAP to Non-GAAP Financial Measures(1) |
||||||||||||||||||||||||
(In thousands, except per share data) | ||||||||||||||||||||||||
Unaudited | ||||||||||||||||||||||||
Three Months Ended
|
Six Months Ended
|
|||||||||||||||||||||||
2013 |
2012 |
2013 |
2012 |
|||||||||||||||||||||
GAAP net income | $ | 2,422 | $ | 2,427 | $ | 4,362 | $ | 3,847 | ||||||||||||||||
Interest income | (61 | ) | (39 | ) | (120 | ) | (70 | ) | ||||||||||||||||
Interest expense | 13 | 13 | 25 | 25 | ||||||||||||||||||||
Income tax provision | 1,712 | 1,640 | 2,991 | 2,580 | ||||||||||||||||||||
Share-based compensation expense | 400 | 299 | 710 | 541 | ||||||||||||||||||||
Depreciation and amortization | 1,897 | 1,572 | 3,773 | 3,106 | ||||||||||||||||||||
Adjusted EBITDA | $ | 6,383 | $ | 5,912 | $ | 11,741 | $ | 10,029 | ||||||||||||||||
GAAP revenues | $ | 31,919 | $ | 25,841 | $ | 61,565 | $ | 49,514 | ||||||||||||||||
Add: deferred revenue write-down | 168 | -- | 500 | -- | ||||||||||||||||||||
Non-GAAP revenues | $ | 32,087 | $ | 25,841 | $ | 62,065 | $ | 49,514 | ||||||||||||||||
GAAP operating income | $ | 4,106 | $ | 4,041 | $ | 7,278 | $ | 6,382 | ||||||||||||||||
Add: deferred revenue write-down | 168 | -- | 500 | -- | ||||||||||||||||||||
Non-GAAP operating income | $ | 4,274 | $ | 4,041 | $ | 7,778 | $ | 6,382 | ||||||||||||||||
GAAP net income | $ | 2,422 | $ | 2,427 | $ | 4,362 | $ | 3,847 | ||||||||||||||||
Add: deferred revenue write-down, net of tax | 98 | -- | 297 | -- | ||||||||||||||||||||
Non-GAAP net income | $ | 2,520 | $ | 2,427 | $ | 4,659 | $ | 3,847 | ||||||||||||||||
(1) This press release contains certain non-GAAP financial measures, including non-GAAP net income, non-GAAP operating income, non-GAAP revenue, and adjusted EBITDA, which are used by management in analyzing its financial results and ongoing operational performance. |
||||||||||||||||||||||||
This press release includes certain forward-looking statements
(statements other than solely with respect to historical fact),
including statements regarding expectations for the financial
performance for 2013 that involve risks and uncertainties regarding
Chief
Financial Officer
ir@healthstream.com
or
Media:
Associate Vice President,
mollie.condra@healthstream.com
Source:
News Provided by Acquire Media